As immunogenic cell death signals have been shown to reduce intratumoral Treg populations [53], further investigation into the relationship between tumor GPX4 expression, anti-PD-1/CTLA-4 treatment, anti PD-L1/other ICI regimens, and Treg function is warranted. This evidence concerns the gene GPX4 and neoplasm.